Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Deutsche Boerse AG  >  Canntab Therapeutics Limited    TBF1   CA1377991023

CANNTAB THERAPEUTICS LIMITED

(TBF1)
  Report
SummaryQuotesChartsNewsCompanyFinancials 
Valuation
Fiscal Period: May 2018 2019 2020
Capitalization1 20,818,532,1
Entreprise Value (EV)1 16,616,930,7
P/E ratio -7,46x-7,51x-10,2x
Yield ---
Capitalization / Revenue 780 440 057x76 974 562x240 767 156x
EV / Revenue 622 272 659x70 353 793x230 537 065x
EV / EBITDA -11,0x-8,45x-13,5x
Price to Book 5,00x8,15x9,10x
Nbr of stocks (in thousands) 24 48525 30732 758
Reference price (CAD) 0,850,730,98
Last update 09/30/201909/28/202009/28/2020
1 CAD in Million
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: May 2017 2018 2019 2020
Net sales -0,030,240,13
EBITDA1 -1,11-1,50-2,00-2,27
Operating profit (EBIT)1 -1,12-1,55-2,08-2,45
Operating Margin --5 829%-866%-1 835%
Pre-Tax Profit (EBT)1 -1,12-2,41-2,46-2,61
Net income1 -1,12-2,41-2,46-2,61
Net margin --9 031%-1 024%-1 955%
EPS2 -0,07-0,11-0,10-0,10
Dividend per Share ----
Last update 09/28/201809/30/201909/28/202009/28/2020
1 CAD in Million
2 CAD
Balance Sheet Analysis
Fiscal Period: May 2017 2018 2019 2020
Net Debt1 ----
Net Cash position1 0,964,221,591,36
Leverage (Debt / EBITDA) 0,86x2,81x0,80x0,60x
Free Cash Flow --0,79-1,28-1,77
ROE (Net Profit / Equities) --90,2%-74,8%-90,0%
Shareholders' equity1 -2,673,292,90
ROA (Net Profit / Asset) --33,0%-35,4%-37,8%
Assets1 -7,306,956,91
Book Value Per Share2 0,220,170,090,11
Cash Flow per Share2 0,200,030,020,06
Capex1 0,100,110,250,79
Capex / Sales -398%104%593%
Last update 09/28/201809/30/201909/28/202009/28/2020
1 CAD in Million
2 CAD
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (CAD)
28 085 635
Capitalization (USD)
22 070 185
Net sales (CAD)
133 334
Net sales (USD)
104 826
Free-Float
76,3%
Free-Float capitalization (CAD)
21 422 202
Free-Float capitalization (USD)
16 833 943
Avg. Exchange 20 sessions (CAD)
105
Avg. Exchange 20 sessions (USD)
82,8
Average Daily Capital Traded
0,00%
EPS & Dividend